Blog

Held at the Johns Hopkins Bloomberg Center in Washington, DC, the 2024 symposium welcomed ~ 103 attendees who shared insights and assessed progress. It charted a collective course of action to combat the threat posed by substandard and falsified drugs. Through enlightening keynote addresses and interactive discussions, the event emphasized the importance of a multifaceted public health response through prevention, detection, and response strategies rooted in digital and physical surveillance, capacity building, regulatory enforcement, and Read more…

Issue 5 of SF Pulse is out now! The issue highlights the following: A call to World Health Organization to expand its existing Prequalification of Medicines Programme, which helps ensure enforcement of quality standards for a wide range of medical products. How counterfeiters are now successfully replicating packaging QR codes intended to help regulators discern safe medicines from  substandard ones. An innovative method for falsified or substandard vaccines that does not require them to open the Read more…

Issue 4 of SF Pulse is out now! The newest issue dives into five topics including: A deep dive into how Johnson & Johnson starts thinking about anti-counterfeiting needs well before the product launch. An article by the Global Initiative Against Transnational Organized Crime highlighting the risks that an increased inflow of synthetic opioids, which are used in counterfeit and falsified medicines, could pose to Europe. A sneak peek of the Nigerian government’s successful efforts Read more…